
Measles resurges in a South Carolina county as vaccination gaps widen
Read Our Expert Analysis
Create an account or login for free to unlock our expert analysis and key takeaways for this development.
By continuing, you agree to receive marketing communications and our weekly newsletter. You can opt-out at any time.
Recommended for you

HHS Secretary Kennedy Reclassifies Multiple Childhood Vaccines to Shared Clinical Decisionmaking
HHS moved five childhood vaccines out of routine recommendations into shared clinical decisionmaking, a policy shift announced in January 2026 that reorders federal authority over immunization guidance. This change immediately raises operational burdens for pediatric clinicians, threatens localized coverage levels, and shifts power away from advisory experts toward political leadership.
Research Links Lasting COVID Harms to Policy Retreat on Vaccines and Funding
A growing body of studies ties SARS‑CoV‑2 infection to persistent neurological, cardiovascular and oncological risks, with measurable societal costs. Those findings arrive as federal guidance and funding for COVID vaccines and mRNA development have been narrowed, raising concerns among scientists about future public health and economic strain.
Robert F. Kennedy Jr. Reorients U.S. Vaccine Strategy, Pressures Gavi
HHS Secretary Robert F. Kennedy Jr. has tied U.S. financial support to a timetable for removing the preservative thimerosal from vaccines supplied to low-resource settings, and a U.S.-backed newborn hepatitis B trial in Guinea-Bissau is now at risk as ethics and funding questions mount. Public-health bodies say the science does not support safety-driven removal, making the move politically driven and likely to fragment procurement, raise costs, and slow research and immunization programs.

RFK Jr. departs from key vaccine pledges during first year as HHS secretary
After narrowly winning Senate confirmation, HHS Secretary Robert F. Kennedy Jr. has reversed or undermined several commitments he made about vaccine policy and funding. His actions—reconstituting the vaccine advisory panel, rescinding broad CDC immunization recommendations and pausing large research and grant streams—have immediate legal, public-health and political ramifications.